Insights on the Newly Approved Subcutaneous Infusion Therapy for Parkinson Disease

Jonathan Rubin, MD, MBA, chief medical officer at Supernus Pharmaceuticals, talked about the recent approval of the company’s subcutaneous infusion therapy SPN-830 for Parkinson disease.:

Source: Neurology Read More